Nevirapine induced Stevens-Johnson syndrome: a case report
Keywords:
Stevens-Johnson syndrome, Nevirapine, HIVAbstract
Stevens-Johnson syndrome (SJS) is a severe mucocutaneous skin reaction with extensive necrosis and detachment of the epidermis. Nevirapine is one of the high risk agents implicated in development of SJS. Here, we present a case of 27 years old male with HIV infection who was diagnosed to have SJS following administration of nevirapine.
Metrics
References
Flexner C. Antiretroviral agents and treatment of HIV infection. In: Brunton L, Chabner BA, Knollman B, editors. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 12th Edition. San Diego: The McGraw-Hill Companies, Inc.; 2011: 1462.
Available from: http://www.naco.gov.in . [Last updated on 2014 Mar 12].
Valeyrie-Allanore L, Roujeau JC. Epidermal necrolysis (Stevens-Johnson Syndrome and toxic epidermal necrolysis). In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick's Dermatology in General Medicine. 8th Edition. New York: The McGraw-Hill Companies, Inc.; 2012: 439-48.
Berger TG. Dermatologic disorders. In: Papadakis MA, McPhee SJ, editors. 2013 Current Medical Diagnosis & Treatment. 52nd Edition. New York: The McGraw-Hill Companies, Inc.; 2013: 134.
Endorf FW, Cancio LC, Gibran NS. Toxic epidermal necrolysis clinical guidelines. J Burn Care Res. 2008;29(5):706-12. [DOI via Crossref]
